176 related articles for article (PubMed ID: 30056760)
21. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease.
Bernstein DL; Hülkova H; Bialer MG; Desnick RJ
J Hepatol; 2013 Jun; 58(6):1230-43. PubMed ID: 23485521
[TBL] [Abstract][Full Text] [Related]
22. Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene.
Pisciotta L; Fresa R; Bellocchio A; Pino E; Guido V; Cantafora A; Di Rocco M; Calandra S; Bertolini S
Mol Genet Metab; 2009 Jun; 97(2):143-8. PubMed ID: 19307143
[TBL] [Abstract][Full Text] [Related]
23. Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease.
Lohse P; Maas S; Sewell AC; van Diggelen OP ; Seidel D
J Lipid Res; 1999 Feb; 40(2):221-8. PubMed ID: 9925650
[TBL] [Abstract][Full Text] [Related]
24. Different missense mutations in histidine-108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals.
Ries S; Büchler C; Schindler G; Aslanidis C; Ameis D; Gasche C; Jung N; Schambach A; Fehringer P; Vanier MT; Belli DC; Greten H; Schmitz G
Hum Mutat; 1998; 12(1):44-51. PubMed ID: 9633819
[TBL] [Abstract][Full Text] [Related]
25. A novel lysosomal acid lipase gene mutation in a patient with cholesteryl ester storage disease.
Redonnet-Vernhet I; Chatelut M; Salvayre R; Levade T
Hum Mutat; 1998; 11(4):335-6. PubMed ID: 9554751
[TBL] [Abstract][Full Text] [Related]
26. Homozygous familial hypercholesterolaemia: update on management.
France M
Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
[TBL] [Abstract][Full Text] [Related]
27. Familial hypercholesterolaemia: effect of low density lipoproteins on esterification of cholesterol in lymphocytes from homozygous and heterozygous subjects.
Hammond KD; Khan Q; Laminski NA; Mendelsohn D; Seftel HC
Arch Int Physiol Biochim; 1987 Mar; 95(1):75-80. PubMed ID: 2441677
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Algorithm for Cholesteryl Ester Storage Disease: Clinical Presentation in 19 Polish Patients.
Lipiński P; Ługowska A; Zakharova EY; Socha P; Tylki-Szymańska A
J Pediatr Gastroenterol Nutr; 2018 Oct; 67(4):452-457. PubMed ID: 29958253
[TBL] [Abstract][Full Text] [Related]
29. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.
Ohta N; Hori M; Takahashi A; Ogura M; Makino H; Tamanaha T; Fujiyama H; Miyamoto Y; Harada-Shiba M
J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942
[TBL] [Abstract][Full Text] [Related]
30. Identification and molecular characterisation of Lausanne Institutional Biobank participants with familial hypercholesterolaemia - a proof-of-concept study.
Maurer F; Pradervand S; Guilleret I; Nanchen D; Maghraoui A; Chapatte L; Bojkowska K; Bhuiyan ZA; Jacquemont N; Harshman K; Mooser V
Swiss Med Wkly; 2016; 146():w14326. PubMed ID: 27497240
[TBL] [Abstract][Full Text] [Related]
31. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
[TBL] [Abstract][Full Text] [Related]
32. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
[TBL] [Abstract][Full Text] [Related]
33. Identification of rare diseases by screening a population selected on the basis of routine pathology results-the PATHFINDER project: lysosomal acid lipase/cholesteryl ester storage disease substudy.
Reynolds TM; Mewies C; Hamilton J; Wierzbicki AS;
J Clin Pathol; 2018 Jul; 71(7):608-613. PubMed ID: 29358478
[TBL] [Abstract][Full Text] [Related]
34. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
Bourbon M; Rato Q;
Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
[TBL] [Abstract][Full Text] [Related]
37. Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis.
Reynolds T
J Clin Pathol; 2013 Nov; 66(11):918-23. PubMed ID: 23999269
[TBL] [Abstract][Full Text] [Related]
38. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer.
Matsuzawa Y; Yamashita S; Funahashi T; Yamamoto A; Tarui S
Am J Cardiol; 1988 Jul; 62(3):66B-72B. PubMed ID: 3394656
[TBL] [Abstract][Full Text] [Related]
39. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
40. Cholesteryl ester storage disease: relationship between molecular defects and in situ activity of lysosomal acid lipase.
Redonnet-Vernhet I; Chatelut M; Basile JP; Salvayre R; Levade T
Biochem Mol Med; 1997 Oct; 62(1):42-9. PubMed ID: 9367797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
